Company Encyclopedia
View More
name
FUDAN FORWARD
600624.SH
Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations, as well as chemical raw materials, digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory system drugs, and traditional and modern Chinese medicines. It is also involved in the development of high-tech parks; and development, production, and sale of uninterruptible power supplies and lead-acid batteries, as well as professional agent of car audio brand. In addition, the company provides corporate investment and consulting, and venture capital investment solutions.
3.157 T
600624.SHMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
PharmaceuticalsIndustry
Industry Ranking206/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-17.07%E
    • Profit Margin-18.00%D
    • Gross Margin34.74%C
  • Growth ScoreD
    • Revenue YoY3.49%C
    • Net Profit YoY-95.18%E
    • Total Assets YoY-2.36%D
    • Net Assets YoY-18.91%E
  • Cash ScoreD
    • Cash Flow Margin-555.61%E
    • OCF YoY3.49%C
  • Operating ScoreC
    • Turnover0.43C
  • Debt ScoreD
    • Gearing Ratio56.99%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    FUDAN FORWARD: Abnormal fluctuations in stock trading, with a net loss of over 18 million yuan in the first three quarters

    FUDAN FORWARD announced that due to the cumulative deviation of the closing price increase exceeding 12% for three consecutive trading days from October 30 to November 3, 2025, it constitutes an abnormal fluctuation. After self-examination, the company and its controlling shareholders found no significant undisclosed information, and there have been no significant changes in daily operations. The net profit attributable to the parent company for the first three quarters of 2025 was -18.0165 million yuan, and the net profit excluding non-recurring gains and losses was -23.3019 million yuan. Additionally, due to receiving a notice of punishment in advance, the stock has been subjected to other risk warnings

    Zhitong·
    SH
    600624
    +2.30%
    Zhitong·
    SH
    600624
    +2.30%

    FUDAN FORWARD: Plans to purchase directors and officers liability insurance not exceeding 416,000 yuan, with a limit of 50 million yuan per year

    Fudan Forward announced that the company plans to purchase liability insurance for directors and senior management, with a premium not exceeding 416,000 yuan, a compensation limit of 50 million yuan per year, and an insurance period of 12 months. This matter will be submitted to the shareholders' meeting for deliberation, and the board of directors intends to request the shareholders' meeting to authorize the management to handle related matters

    Zhitong·
    SH
    600624
    +2.30%
    Zhitong·
    SH
    600624
    +2.30%

    FUDAN FORWARD: The controlling shareholder has completed the commitment to resolve the competition with peers

    Fudan Forward announced that its controlling shareholder, Fengtou Group, has fulfilled its commitment to avoid competition in the same industry. When Fengtou Group acquired the 18.74% stake held by Fudan University in 2019, it promised to resolve the competition issue within three years, which was later extended by two years after review by the shareholders' meeting. The separation of the "Baicun Park Business" has now been completed through equity transfer and other means, ensuring no direct competition with the company. The financial advisor has verified and confirmed that Fengtou Group has fulfilled its commitment

    Zhitong·
    SH
    600624
    +2.30%
    Zhitong·
    SH
    600624
    +2.30%

    FUDAN FORWARD: There is no undisclosed significant information that should be disclosed

    Fudan Forward Technology Co., Ltd. announced that its stock price has recently experienced abnormal fluctuations, with a cumulative decline of over 12%. After self-examination and communication with the controlling shareholder, it confirmed that there is no significant information that should be disclosed, and there are no major changes in daily operations. The company reminds investors to pay attention to market trading risks and operational risks, and due to receiving a notice of punishment, the stock has been subjected to other risk warnings

    Zhitong·
    SH
    600624
    +2.30%
    Zhitong·
    SH
    600624
    +2.30%

    4 A-share companies will be ST due to financial fraud

    On the evening of September 19th, four A-share companies, FUDAN FORWARD, SCREEN, JUEWEI FOOD, and Troy Information, announced that they would suspend trading for one day on September 22nd due to financial fraud, implementing other risk warnings. Regulatory authorities have adopted a zero-tolerance approach to financial fraud, with over 30 listed companies penalized this year, enhancing regulatory deterrence and promoting a healthy capital market ecosystem

    Zhitong·
    SZ
    300366
    +3.42%
    SH
    600624
    +2.30%
    SH
    688053
    +10.08%
    Zhitong·
    SZ
    300366
    +3.42%
    SH
    600624
    +2.30%
    SH
    688053
    +10.08%
    © 2025 Longbridge｜Disclaimer